The guardian of the genome meets immunotherapy: p53-based strategies
Originally reported as an oncogene and currently known to be a major “genome guardian”, the p53 protein remains one of the most explored transcription factors, exhibiting variety of functions both within transcription regulation and beyond. Given that …